Company Profile
Estechpharma Co., Ltd. Strives to be a leading manufacturer of Active Pharmaceutical Ingredients (API) and intermediates for pharmaceuticals with a uniquely broad spectrum of the innovative produced in our manufacturing facility in Korea under full B-GMP compliance. Product; Acamprosate Calcium (CEP acquired), Aceclofenac( CEP Processing), Acemetacin, Afloqualone, Bendazac lysine, Caroverine, droxidopa, Ferric sodium gluconate complex, Glimepiride, Gadopentetic acid monomeglumine salt, Levosulpiride, Policresulen, Polysaccharide Iron Complex, Quinupramine, Roxatidine, Suplatast tosylate, Tamsulosin, Tiropramide, Triflusal ( CEP Processing ), L,D,DL-Penicillamine. We will continue to explore new technologies and products and bring improvement to our Active Pharmaceutical Ingredients by offering regulatory documentation ( EU-DMF and CEP) for our several existing products.
